Bharat Immunologicals & Biologicals Corporation Ltd.
BSE: 524663
₹17.26
₹-0.21
(-1.20%)
As on 19-May-2026IST
Market cap
₹75 Cr
Revenue (TTM)
₹45 Cr
P/E Ratio
--
P/B Ratio
--
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-17 Cr
-
ROE
0 %
-
ROCE
-25.6 %
-
Industry P/E
--
-
EV/EBITDA
-9.3
-
Debt to Equity
-3
-
Book Value
₹-5.3
-
EPS
₹-3.9
-
Face value
10
-
Shares outstanding
43,180,000
10 Years Aggregate
CFO
₹-45.36 Cr
EBITDA
₹-45.38 Cr
Net Profit
₹-55.52 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bharat Immuno
| -14.0 | -3.5 | -7.7 | -26.2 | -8.9 | -21.3 | -1.5 |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bharat Immuno
| -17.9 | -32.2 | -11.4 | -31.7 | 12.0 | 598.8 | -38.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bharat Immuno
|
17.3 | 74.5 | 44.6 | -16.6 | -- | 0 | -- | -- |
| 188.3 | 2,956.2 | 2,796.8 | 118.8 | 8.1 | 2.3 | 24.9 | 0.5 | |
| 24.3 | 7.4 | 0.5 | 0.0 | 8.3 | -1.1 | -- | 1.9 | |
| 511.4 | 12,318.5 | 3,510.5 | 401.1 | 14.0 | 13.9 | 30.7 | 3.9 | |
| 59.7 | 211.1 | 133.8 | -0.3 | -0.7 | -0.6 | -- | 2.1 | |
| 217.3 | 9,860.8 | 2,803.3 | 361.8 | 15.5 | 14 | 27.4 | 3.5 | |
| 1,125.4 | 23,871.5 | 2,192.5 | 348.9 | 21.2 | 14.9 | 68.4 | 9.6 | |
| 4,789.4 | 11,053.0 | 935.0 | 257.9 | 34.3 | 78.9 | 42.9 | 24.5 | |
| 25.5 | 375.6 | 0.0 | 1.6 | -- | -0.5 | 233.4 | 14.0 | |
| 26.9 | 59.6 | 51.4 | 4.5 | 22.0 | 5.2 | 13.2 | 0.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Bharat Immuno
Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, ready to use therapeutic... food, low calorie sweetener tablets, etc. The company was founded in 1989 and is based in Bulandshahr, India. Read more
-
Incorporated
1989
-
Chairman
Sudhanshu Vrati
-
Managing Director
Dhananjay Kumar Tiwary
-
Group
PSU
-
Headquarters
Bulandshahar, Uttar Pradesh
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Bharat Immuno
What is the current share price of Bharat Immunologicals & Biologicals Corporation Ltd Today?
The share price of Bharat Immunologicals & Biologicals Corporation Ltd is ₹17.26 (BSE) as of 19-May-2026 IST. Bharat Immunologicals & Biologicals Corporation Ltd has given a return of -8.87% in the last 3 years.
What is the current PB & PE ratio of Bharat Immunologicals & Biologicals Corporation Ltd?
Since, TTM earnings of Bharat Immunologicals & Biologicals Corporation Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
0.00
|
-4.16
|
|
2022
|
0.00
|
-18.98
|
|
2021
|
0.00
|
83.21
|
|
2020
|
0.00
|
1.23
|
|
2019
|
0.00
|
1.08
|
What is the 52 Week High and Low of Bharat Immunologicals & Biologicals Corporation Ltd?
The 52-week high and low of Bharat Immunologicals & Biologicals Corporation Ltd are Rs 28.80 and Rs 14.10 as of 20-May-2026.
What is the market cap of Bharat Immunologicals & Biologicals Corporation Ltd?
Bharat Immunologicals & Biologicals Corporation Ltd has a market capitalisation of ₹ 75 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bharat Immunologicals & Biologicals Corporation Ltd?
Before investing in Bharat Immunologicals & Biologicals Corporation Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.